Global Ventricular Assist Device Market Growth 2025-2031

The global Ventricular Assist Device market size is predicted to grow from US$ 1623 million in 2025 to US$ 2637 million in 2031; it is expected to grow at a CAGR of 8.4% from 2025 to 2031.

Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts. A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.

Market Driver: The growing prevalence of heart failure and cardiovascular diseases is a key driver for the Ventricular Assist Device (VAD) market. As the global aging population increases, so does the number of patients suffering from end-stage heart failure, leading to a higher demand for VADs as both a bridge-to-transplant and destination therapy. Additionally, advancements in VAD technology, such as smaller, more durable, and biocompatible devices with reduced complications, have improved patient outcomes and expanded the adoption of these devices. Government initiatives, increasing healthcare expenditures, and rising awareness of mechanical circulatory support systems further fuel market growth.

Market Challenge: Despite its growth, the VAD market faces significant challenges, primarily related to high costs and surgical risks. The implantation procedure for VADs is complex, requiring skilled surgeons and advanced medical infrastructure, which limits accessibility, especially in developing regions. Moreover, post-implantation complications, such as infections, thromboembolism, and device malfunction, remain concerns, necessitating continuous monitoring and long-term patient management. Regulatory hurdles and reimbursement limitations in certain countries also pose barriers to widespread adoption, slowing market expansion.

LP Information, Inc. (LPI) ' newest research report, the “Ventricular Assist Device Industry Forecast” looks at past sales and reviews total world Ventricular Assist Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Ventricular Assist Device sales for 2025 through 2031. With Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ventricular Assist Device industry.

This Insight Report provides a comprehensive analysis of the global Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ventricular Assist Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ventricular Assist Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
LVADs
RVADs
BIVADs

Segmentation by Application:
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Evaheart
CH Biomedical
ROCOR Medical
coretech medical
BiVACOR
CorWave

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ventricular Assist Device market?

What factors are driving Ventricular Assist Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ventricular Assist Device market opportunities vary by end market size?

How does Ventricular Assist Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.